{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:36:12Z","timestamp":1790202972694,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.transproceed.2017.01.047","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T11:17:59Z","timestamp":1493291879000},"page":"852-857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Immunomodulation, Acute Renal Failure, and Complications of Basiliximab Use After Liver Transplantation: Analysis of 114 Patients and Literature Review"],"prefix":"10.1016","volume":"49","author":[{"given":"E.C.","family":"de Ataide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.R.","family":"Perales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.B.","family":"Bortoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.O.","family":"Peres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.C.","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.S.B.","family":"Stucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Udo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.F.S.F.","family":"Boin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2017.01.047_bib1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1600-6143.2007.02057.x","article-title":"A\u00a0randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients","volume":"8","author":"Vincenti","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2017.01.047_bib2","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.jhep.2010.12.001","article-title":"Immunosuppression in liver transplant recipients with renal impairment","volume":"54","author":"Duvoux","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.transproceed.2017.01.047_bib3","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"7393","key":"10.1016\/j.transproceed.2017.01.047_bib4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1136\/bmj.326.7393.789","article-title":"Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials","volume":"326","author":"Adu","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.transproceed.2017.01.047_bib5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/01.TP.0000109643.32659.C4","article-title":"Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials","volume":"77","author":"Webster","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2017.01.047_bib6","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1432-2277.2011.01250.x","article-title":"Outcome of induction immunosuppression for liver transplantation comparing antithymocyte globulin, daclizumab, and corticosteroid","volume":"24","author":"Uemura","year":"2011","journal-title":"Transpl Int"},{"issue":"9158","key":"10.1016\/j.transproceed.2017.01.047_bib7","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(98)07493-5","article-title":"Immunosuppressive strategies in transplantation","volume":"353","author":"Denton","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2017.01.047_bib8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1517\/14712598.7.1.137","article-title":"The role of basiliximab induction therapy in organ transplantation","volume":"7","author":"Ramirez","year":"2007","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.transproceed.2017.01.047_bib9","series-title":"Primer on transplantation","first-page":"152","article-title":"Action, efficacy and toxicities: polyclonal antilymphocyte antibodies","author":"Brennan","year":"2001"},{"issue":"6","key":"10.1016\/j.transproceed.2017.01.047_bib10","first-page":"192","article-title":"Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients","author":"Penninga","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.transproceed.2017.01.047_bib11","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2017.01.047_bib12","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1097\/TP.0b013e3182384aff","article-title":"Early changes in kidney function predict long-term chronic kidney disease and mortality in patients after liver transplantation","volume":"92","author":"Cantarovich","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2017.01.047_bib13","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1016\/j.transproceed.2012.07.028","article-title":"Can pre-liver transplantation renal insufficiency using a creatinine clearance calculator predict long-term survival?","volume":"44","author":"Boin","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2017.01.047_bib14","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/j.1600-6143.2009.02880.x","article-title":"The influence of induction therapy on graft and patient survival in patients with and without hepatitis C after liver transplantation","volume":"10","author":"Moonka","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2017.01.047_bib15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1600-6143.2008.02493.x","article-title":"Delayed introduction of reduced dose tacrolimus, and renal function in liver transplantation: the \u201cRESPECT\u201d study","volume":"9","author":"Neuberger","year":"2009","journal-title":"Am J Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113451730057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113451730057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T09:27:00Z","timestamp":1535880420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004113451730057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S004113451730057X"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.01.047","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulation, Acute Renal Failure, and Complications of Basiliximab Use After Liver Transplantation: Analysis of 114 Patients and Literature Review","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.01.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}